Double ECMO in severe ARDS: report of an outstanding case and literature review

Litmathe, Jens; Dapunt, Otto
November 2010
Perfusion;Nov2010, Vol. 25 Issue 6, p363
Academic Journal
Case Study
We report on a 49-year-old male patient who suffered from severe herpes simplex (HSV) pneumonia after a fall-from-height injury, causing a circumscript type B aortic dissection.The subsequent occurrence of ARDS required a veno-venous ECMO circuit that was upgraded to a veno-arterial system due to further oxygenation deficits. Following continued respiratory deterioration, the ECMO system already in place had to be complemented by a second veno-arterial line. After the onset of recovery and because of a developing of a disseminated intravasal coagulation, the double ECMO circuit was replaced by a pumpless extracorporeal lung assist system (PECLA). The patient recovered completely under systemic virostatic therapy.


Related Articles

  • Long-segment caval thrombus after removal of ECMO cannula. Bein, Thomas; Philipp, Alois; Pregler, Benedikt; Noeva, Ekaterina; Graf, Bernhard; Stroszczynski, Christian; Graf, Bernhard M // Intensive Care Medicine;Nov2015, Vol. 41 Issue 11, p1967 

    The article presents a case study which involves a 21-year-old male patient that developed long-segment caval thrombus following the removal of his extracorporeal membrane oxygenation (ECMO) support system. Topics discussed include the need of the patient for an ECMO due to his acute respiratory...

  • Extracorporeal Membrane Oxygenation as a First-Line Treatment Strategy for ARDS: Is the Evidence Sufficiently Strong? Checkley, William // JAMA: Journal of the American Medical Association;10/19/2011, Vol. 306 Issue 15, p1703 

    The author looks at the use of extracorporeal membrane oxygenation (ECMO) as early treatment for acute respiratory distress syndrome (ARDS). He references a study by M. A. Noah et al. published within the issue. He cites that the study suggests that the use of ECMO can be immediately established...

  • Extracorporeal membrane oxygenation in burn patients with refractory acute respiratory distress syndrome leads to 28 % 90-day survival. Soussi, Sabri; Gallais, Pauline; Kachatryan, Levon; Benyamina, Mourad; Ferry, Axelle; Cupaciu, Alexandru; Chaussard, Maïté; Maurel, Véronique; Chaouat, Marc; Mimoun, Maurice; Mebazza, Alexandre; Legrand, Matthieu; Chaussard, Maïté; Maurel, Véronique; PRONOBURN Group // Intensive Care Medicine;Nov2016, Vol. 42 Issue 11, p1826 

    The article examines the effectiveness of extracorporeal membrane oxygenation (ECMO) and its impact to the survivability of burn patients with refractory acute respiratory distress syndrome (ARDS). The author highlights the research that seeks to report ECMO usage in the medical practice for the...

  • False Lumen Embolization to Treat Disseminated Intravascular Coagulation After Thoracic Endovascular Aortic Repair of Type B Aortic Dissection. Mendes, Bernardo C.; Oderich, Gustavo S.; Erben, Young; Reed, Nanette R.; Pruthi, Rajiv K. // Journal of Endovascular Therapy (Sage Publications Inc.);Dec2015, Vol. 22 Issue 6, p938 

    Purpose: To present a rare case of disseminated intravascular coagulation (DIC) after thoracic endovascular aortic repair (TEVAR) and its novel treatment.Case Report: A 55-year-old man presented with DIC 10 months after TEVAR for chronic type B aortic dissection and...

  • Yaygın damar içi pıhtılaÅŸması saptanan bir hastada yüzeyel "Ankaferd Blood Stopper" kullanımı. Öner, Ahmet Faik; Kaya, Avni; Temel, Hayrettin; Melek, Mehmet; Karaman, Kamuran; Epçapan, Serdar; Beğer, Burhan; Ayhan, Harun // Turkish Pediatrics Archive / Turk Pediatri Arsivi;mar2010, Vol. 45 Issue 1, p64 

    "Ankaferd Blood Stopper©" is a new therapeutic agent which is derived from five different herbal extracts and can stop bleeding within minutes in all type of open hemorrhages. "Ankaferd Blood Stopper©" is the first drug Turkish patent. A 12 years old boy was taken to operation with the...

  • Hepatic Trauma and Massive Transfusion. Hults, Jennifer // International Student Journal of Nurse Anesthesia;Fall2014, Vol. 13 Issue 3, p16 

    No abstract available.

  • ECMO in adults for severe respiratory failure finally comes of age: just in time?  // Thorax;Mar2010, Vol. 65 Issue 3, p194 

    The authors reflect on the study conducted by G. J. Peek and colleagues regarding the performance of extracorporeal membrane oxygenation (ECMO) in patients suffering from severe acute respiratory failure (ARF). The authors say that the study was able to demonstrate that ECMO can lead those with...

  • Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: Conventional ventilation or ECMO for Severe Adult Respiratory Failure (CESAR). Thalanany, Mariamma M.; Mugford, Miranda; Hibbert, Clare; Cooper, Nicola J.; Truesdale, Ann; Robinson, Steven; Tiruvoipati, Ravindranath; Elbourne, Diana R.; Peek, Giles J.; Clemens, Felicity; Hardy, Polly; Wilson, Andrew // BMC Health Services Research;2008, Vol. 8, Special section p1 

    Background: Extracorporeal Membrane Oxygenation (ECMO) is a technology used in treatment of patients with severe but potentially reversible respiratory failure. A multi-centre randomised controlled trial (CESAR) was funded in the UK to compare care including ECMO with conventional intensive care...

  • Too Many Diagnoses: A Hematologist's Dilemma. Aijaz, Asim // Cortlandt Forum;3/25/2002, Vol. 15 Issue 3, p20 

    Presents a case of disseminated intravascular coagulation (DIC). Case history; Differential diagnosis; Clinical feature of DIC.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics